Evidence map›Paper›PMID 30353815›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2018

Two Cases of Sleep-Related Eating Disorder Responding Promptly to Low-Dose Sertraline Therapy.

Ranji Varghese, Jorge Rey de Castro, Cesar Liendo, Carlos H Schenck

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  8. NonREM Disorders of Arousal and Related Parasomnias: an Updated Review.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Ranji VargheseMinnesota Regional Sleep Disorders Center, Minneapolis, Minnesota.
Jorge Rey de CastroDepartamento de Medicina, Escuela de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú.
Cesar LiendoLouisiana State University Multidisciplinary Sleep Clinic at Shreveport, Shreveport, Louisiana.
Carlos H SchenckMinnesota Regional Sleep Disorders Center, Minneapolis, Minnesota.
Louisiana State University in Shreveport · USUniversidad Peruana Cayetano Heredia · PEUniversity of Minnesota · USUniversity of Minnesota Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractWe report two cases of adult males with sleep-related eating disorder (SRED), with durations of 3 and 7 years, and without associated psychiatric history. In both cases, the use of low-dose (25 mg) sertraline taken at bedtime resulted in immediate, full and sustained resolution of symptoms at the latest follow-ups. The sertraline efficacy was of particular benefit for the patient reported on in case 2 who was a commercial airline pilot subjected to a highly restricted list of Federal Aviation Administration-approved medications. Risk factors for SRED included smoking cessation and work-related stress in case 1, and a history of sleepwalking and work-related circadian disruptions and partial sleep deprivations in case 2. Sertraline therapy of SRED is considered within a review of all current pharmacologic therapies of SRED.

Indexed as

AdultFeeding and Eating DisordersHumansMaleParasomniasSelective Serotonin Reuptake InhibitorsSertralineSelective Serotonin Reuptake InhibitorsSertralinenight eating syndromenon-REM parasomniasleep-related eatingsleepwalking

Identifiers

PMID30353815
PMCPMC6175812
OpenAlexW2896290603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.